Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Signet Accel Appoints New Vice President of Marketing Amid Growth

Signet Accel
Posted on: 09 Nov 17

Software and services company Signet Accel announced today that Carolyn Ewing-Turner joined the company as Vice President of Marketing. With more than two decades in strategic healthcare marketing, Ewing-Turner will lead Signet Accel in its global marketing efforts, further establishing the company as a leader in healthcare technology and data integration.

This press release features multimedia. View the full release here:

Carolyn-Ewing Turner, Vice President of Marketing, Signet Accel (Photo: Business Wire)

“We are in a dynamic market. HIT is constantly evolving, and Signet Accel’s Avec® platform is primed to change the face of data integration for the industry,” Ewing-Turner said. “I’m ready to hit the ground running, challenge the status quo and educate the market on what’s possible with Avec.”

Ewing-Turner ‘s experience includes positions with Abbott Laboratories, Johnson & Johnson Medical and Medtronic. Most recently, she was Marketing Director at Cardinal Health.

“Carolyn is highly-focused on objectives and getting things done, but she tackles problems creatively. When she is presented with a challenge—especially one that appears undoable to others—she is driven to take a step back, collaborate, and figure it out,” said Signet Accel Executive Vice President of Sales and Marketing, Brenda Berry. “With her deep experience in healthcare, her eye for process and her spot-on intuition, Carolyn achieves things that seem unachievable. Together, we make an indomitable team.”

Avec®, a federated data integration platform, is the company’s flagship product. Avec® connects disparate databases across healthcare verticals, allowing researchers to identify patterns and trends over a large patient population and offering comprehensive insight into both research and patient treatment. Robust repositories of connected data are a key resource in realizing the promise of precision medicine, a research effort aimed at improving health and treating disease by accounting for patients’ individual differences.

“I’m here to develop and implement a marketing strategy for Avec® that supports our growth and market penetration,” Ewing-Turner said. “It’s an awesome opportunity with a highly collaborative company, but it's also an awesome responsibility, and that excites me.”

With its increasing market penetration and deepening client engagements, Signet Accel is doubling its physical footprint to accommodate a 60 percent increase in staff in 2017.

About Signet Accel

Signet Accel is a leading HIT software and services company specializing in successful data integration, harmonization and sharing in and among consortia, institutions and health professionals around the world. Its flagship product, Avec®, is a federated data integration platform deliberately designed to integrate data in complex environments and deliver true interoperability to healthcare. Signet Accel’s software products and services power the work of its clients by helping them define, deliver and discover—faster—while ensuring all of their health data is ready for the task, more quickly than ever before. Learn how to make your data meaningful and achieve true interoperability at

View source version on

Business Wire

Last updated on: 09/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.